Estimating a cost-effectiveness threshold for health care decision-making in South Africa

por Edoka, Ijeoma P, Stacey, Nicholas K
Publicado no Health Policy Plan (2020)

Healthcare costs of paternal depression in the postnatal period

por Edoka, Ijeoma P., Petrou, Stavros, Ramchandani, Paul G.
Publicado em 2011

Strengthening expertise for health technology assessment and priority-setting in Africa

por Doherty, Jane E, Wilkinson, Thomas, Edoka, Ijeoma, Hofman, Karen
Publicado no Glob Health Action (2017)

Changes in catastrophic health expenditure in post-conflict Sierra Leone: an Oaxaca-blinder decomposition analysis

por Edoka, Ijeoma, McPake, Barbara, Ensor, Tim, Amara, Rogers, Edem-Hotah, Joseph
Publicado no Int J Equity Health (2017)

Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making

por Motaze, Nkengafac Villyen, Edoka, Ijeoma, Wiysonge, Charles S., Metcalf, C. Jessica E., Winter, Amy K.
Publicado no Vaccines (Basel) (2020)

Changes in beverage purchases following the announcement and implementation of South Africa’s Health Promotion Levy: an observational study

por Stacey, Nicholas, Edoka, Ijeoma, Hofman, Karen, Swart, Elizabeth C, Popkin, Barry, Ng, Shu Wen
Publicado no Lancet Planet Health (2021)

Free health care for under-fives, expectant and recent mothers? Evaluating the impact of Sierra Leone’s free health care initiative

por Edoka, Ijeoma, Ensor, Tim, McPake, Barbara, Amara, Rogers, Tseng, Fu-Min, Edem-Hotah, Joseph
Publicado no Health Econ Rev (2016)

A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme

por Edoka, Ijeoma, Kohli-Lynch, Ciaran, Fraser, Heather, Hofman, Karen, Tempia, Stefano, McMorrow, Meredith, Ramkrishna, Wayne, Lambach, Philipp, Hutubessy, Raymond, Cohen, Cheryl
Publicado no Vaccine (2020)

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

por Jo, Youngji, Jamieson, Lise, Edoka, Ijeoma, Long, Lawrence, Silal, Sheetal, Pulliam, Juliet R.C., Moultrie, Harry, Sanne, Ian, Meyer-Rath, Gesine, Nichols, Brooke E
Publicado no medRxiv (2020)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa

por Jo, Youngji, Jamieson, Lise, Edoka, Ijeoma, Long, Lawrence, Silal, Sheetal, Pulliam, Juliet R C, Moultrie, Harry, Sanne, Ian, Meyer-Rath, Gesine, Nichols, Brooke E
Publicado no Open Forum Infect Dis (2021)

Cost–effectiveness of community-based practitioner programmes in Ethiopia, Indonesia and Kenya

por McPake, Barbara, Edoka, Ijeoma, Witter, Sophie, Kielmann, Karina, Taegtmeyer, Miriam, Dieleman, Marjolein, Vaughan, Kelsey, Gama, Elvis, Kok, Maryse, Datiko, Daniel, Otiso, Lillian, Ahmed, Rukhsana, Squires, Neil, Suraratdecha, Chutima, Cometto, Giorgio
Publicado no Bull World Health Organ (2015)

Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015

por Tempia, Stefano, Moyes, Jocelyn, Cohen, Adam L., Walaza, Sibongile, Edoka, Ijeoma, McMorrow, Meredith L., Treurnicht, Florette K., Hellferscee, Orienka, Wolter, Nicole, von Gottberg, Anne, Nguweneza, Athermon, McAnerney, Johanna M., Dawood, Halima, Variava, Ebrahim, Cohen, Cheryl
Publicado no Influenza Other Respir Viruses (2019)

Influenza economic burden among potential target risk groups for immunization in South Africa, 2013–2015

por Tempia, Stefano, Moyes, Jocelyn, Cohen, Adam L., Walaza, Sibongile, McMorrow, Meredith L., Edoka, Ijeoma, Fraser, Heather, Treurnicht, Florette K., Hellferscee, Orienka, Wolter, Nicole, von Gottberg, Anne, McAnerney, Johanna M., Dawood, Halima, Variava, Ebrahim, Cohen, Cheryl
Publicado no Vaccine (2020)

Influenza disease burden among potential target risk groups for immunization in South Africa, 2013–2015

por Tempia, Stefano, Walaza, Sibongile, Moyes, Jocelyn, McMorrow, Meredith L., Cohen, Adam L., Edoka, Ijeoma, Fraser, Heather, Treurnicht, Florette K., Hellferscee, Orienka, Wolter, Nicole, von Gottberg, Anne, McAnerney, Johanna M., Dawood, Halima, Variava, Ebrahim, Cohen, Cheryl
Publicado no Vaccine (2020)

What next after GDP-based cost-effectiveness thresholds?

por Chi, Y-Ling, Blecher, Mark, Chalkidou, Kalipso, Culyer, Anthony, Claxton, Karl, Edoka, Ijeoma, Glassman, Amanda, Kreif, Noemi, Jones, Iain, Mirelman, Andrew J., Nadjib, Mardiati, Morton, Alec, Norheim, Ole Frithjof, Ochalek, Jessica, Prinja, Shankar, Ruiz, Francis, Teerawattananon, Yot, Vassall, Anna, Winch, Alexander
Publicado no Gates Open Res (2020)